RPG Life Sciences Share Price

RPG Life Sciences Share Price

NSE: RPGLIFE
|
Pharmaceuticals
|
S Cap
₹ 2,721.60
+₹69.20 (2.61%)
1D
Last updated 04 Sep, 2026, 15:29 IST

RPG Life Sciences Share Price Today

As of 5 Sep 2026, RPG Life Sciences share price is ₹2,721.60. The stock opened at ₹2,652.40, compared to its previous close of ₹2,652.40. During today's trading session, RPG Life Sciences share price moved in the range of ₹2,638.90 to ₹2,739.00, with an average price of ₹2,688.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,733.00 and a high of ₹3,082.00.

₹2,638.90
2.61% up today
₹2,739.00
1D LOW
1D HIGH

RPG Life Sciences Returns Calculator

Circuit
L
H
₹2,177.30
₹3,265.90
52-week
L
H
₹1,733.00
₹3,082.00

About RPG Life Sciences

RPG Life Sciences Share Price
ISIN
INE105J01010
Sector Market Cap
₹ 4,401.2 Cr

RPG Life Sciences Limited is an India-based research-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations, and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has a presence in nephrology, oncology, rheumatology, cardiology, respiratory, pain management, vitamins & minerals, gastroenterology, and gynecology & pediatrics. The International Formulations business operates in the generics and branded generics space across Canada, Europe, Australia, New Zealand, and South America. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Quinfamide, Nicorandil, Haloperidol, Risperidone, Tolvaptan, Spironolactone, Sertraline, Naprosyn, Teristrong, and others.

RPG Life Sciences Financial Highlights

  • Revenue: RPG Life Sciences reported revenue of ₹733.10 crore in FY26 vs ₹666.11 crore in FY25. It showed an increase of 10.06% on a yearly basis.
  • Operating Profit: RPG Life Sciences reported an operating profit of ₹154.20 crore in FY26 vs ₹232.88 crore in FY25. It showed a decrease of 33.79% on a year-on-year basis.
  • Net Profit: RPG Life Sciences reported a net profit of ₹115.17 crore in FY26 vs ₹183.24 crore in FY25. It showed a decrease of 37.15% on a yearly basis.

RPG Life Sciences Quarterly Result Highlights

  • RPG Life Sciences reported revenue of ₹200.39 crore in Jun 2026, compared with ₹189.29 crore in Mar 2026, representing an increase of 5.86% on a quarter-on-quarter (QoQ) basis.
  • RPG Life Sciences reported an operating profit of ₹41.46 crore in Jun 2026, compared with ₹40.20 crore in Mar 2026, representing an increase of 3.13% on a quarter-on-quarter (QoQ) basis.
  • RPG Life Sciences reported a profit of ₹30.76 crore in Jun 2026, compared with ₹29.90 crore in Mar 2026, reflecting an increase of 2.88% on a QoQ basis.
  • The earnings per share (EPS) of RPG Life Sciences stood at ₹69.64 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.95%
FII
0.95%
Other DII
8.63%
Retail and other
17.42%
Mutual funds
0.04%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20251.11%
Dec 20251.00%
Mar 20260.87%
Jun 20260.95%
Mkt Cap Cr
4,401.20
P/E
37.52
P/B
7.42
ROE
19.03%
D/E
0.03
ROCE
24.66%
Div. Yield
0.90%
EPS(TTM)
69.64
Turnover
0.93
EV/EBITDA
22.93
Net Margin
16.28%
Op. Margin
25.08%
ROA
15.08%
Quick Ratio
2.50
Curr. Ratio
3.41
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
RPG LifeScience. has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
RPG LifeScience. appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
RPG LifeScience. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,56,833.0037.605.4513.74%0.6117.33%93.240.84%0.4810.90
Divis Laboratories2,45,426.0082.5914.4115.32%0.0019.56%629.490.33%0.5598.19
Torrent Pharmaceuticals1,87,320.0085.5721.9425.49%1.6913.85%222.760.70%0.4958.70
Zydus Lifesciences1,13,217.0024.354.1218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,12,212.0033.343.2511.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs99,417.5091.1818.7616.77%0.4016.14%97.200.11%0.6713.72
Lupin97,626.3017.394.3023.76%0.0424.88%659.000.85%0.57129.18
Mankind Pharma96,179.6046.525.9011.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories96,405.5030.262.5311.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma93,614.0025.642.519.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

RPG Life Sciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Revenue₹707.52₹653.43
Other Income₹25.58₹12.68
Total Revenue₹733.10₹666.11
Total Expenses₹582.80₹515.83
Profit Before Tax₹154.20₹232.88
Tax₹39.03₹49.64
Profit After Tax₹115.17₹183.24
EPS - Basic₹69.64₹110.80
EPS - Diluted₹69.64₹110.80

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Profit before tax₹154.20₹232.88
Income before WC changes₹136.89₹156.66
Change in Assets-₹76.45-₹24.20
Change in Liabilities₹33.28-₹1.85
Change in WC-₹43.17-₹26.05
Cash flow from Operations₹56.50₹77.86
Cash flow from Investing₹85.84-₹41.80
Cash flow from Financing-₹20.58-₹27.08
Total Cash Flow₹121.76₹8.98
Cash (Start of the year)₹28.70₹19.72
Cash (End of the year)₹150.46₹28.70

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Non-Current Assets₹233.68₹192.56
Current Assets₹559.48₹465.25
Total Assets₹793.16₹657.81
Current Liabilities₹160.57₹119.83
Net Current Asset₹398.91₹345.42
Non-Current Liabilities₹27.24₹7.45
Equity Capital₹605.35₹530.53
Total Equity & Liabilities₹793.16₹657.81

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹707.52₹653.43₹582.05₹512.81
Other Income₹25.54₹12.68₹7.21₹4.80
Total Revenue₹733.06₹666.11₹589.26₹517.61
Total Expenses₹582.76₹515.83₹471.42₹425.93
Profit Before Tax₹154.20₹232.88₹117.84₹91.68
Tax₹39.03₹49.64₹30.18₹24.04
Profit After Tax₹115.17₹183.24₹87.66₹67.64
EPS - Basic₹69.64₹110.80₹53.01₹40.90
EPS - Diluted₹69.64₹110.80₹53.01₹40.90

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹154.20₹232.88₹117.84₹91.68
Income before WC changes₹136.89₹156.66₹130.76₹104.99
Change in Assets-₹76.44-₹24.20-₹25.44-₹12.96
Change in Liabilities₹33.26-₹1.85₹18.35₹24.02
Change in WC-₹43.18-₹26.05-₹7.09₹11.06
Cash flow from Operations₹56.50₹77.86₹94.36₹90.82
Cash flow from Investing₹51.06-₹41.80-₹79.15-₹105.81
Cash flow from Financing-₹20.58-₹27.08-₹20.31-₹17.12
Total Cash Flow₹86.98₹8.98-₹5.10-₹32.11
Cash (Start of the year)₹28.70₹19.72₹24.82₹56.94
Cash (End of the year)₹115.68₹28.70₹19.72₹24.83

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹268.45₹192.56₹214.78₹155.30
Current Assets₹524.69₹465.25₹298.09₹264.05
Total Assets₹793.14₹657.81₹512.87₹419.35
Current Liabilities₹160.53₹119.83₹130.96₹102.78
Net Current Asset₹364.16₹345.42₹167.13₹161.27
Non-Current Liabilities₹27.24₹7.45₹7.06₹8.97
Equity Capital₹605.37₹530.53₹374.85₹307.60
Total Equity & Liabilities₹793.14₹657.81₹512.87₹419.35
* All values are in INR Crore
Qty
Bid
11
2721.6
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 11
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
3
Neutral
3
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
55.69
Neutral
ATR (14)
82.16
Neutral
STOCH(9,6)
93.01
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
19.6
Bullish
UO(9)
49.97
Neutral
ROC(12)
2.02
Bullish
WillR(14)
-17.29
Bearish
Period
Simple value
Exponential vaue
5D
2631.68
2645.36
10D
2606.42
2633.47
20D
2648.21
2649.78
50D
2689.52
2617.12
100D
2451.4
2496.78
Volume trend — traded volume by day
4 Sep0L
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
RPG Life Sciences Share Price
RPG Life Sciences
Pharmaceuticals
Add Stock
Add Another

RPG Life Sciences Share Price FAQs

RPG Life Sciences share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837